Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 6 (2009), Issue 1 (January)

1. Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study.
   Br J Psychiatry, 194(1): 40-8. [Abstract] [Full-text]
2. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials.
   Br J Psychiatry, 194(1): 4-9. [Abstract] [Full-text]
3. A single photon emission computerized tomography (SPECT) study of regional cerebral blood flow in bipolar disorder.
   World J Biol Psychiatry. [Abstract] [Full-text]
4. A role for the circadian genes in drug addiction.
   Neuropharmacology, 56: 91-6. [Abstract] [Full-text]
5. Penn/VA center for studies of addiction.
   Neuropharmacology, 56: 44-7. [Abstract] [Full-text]
6. Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of Mania.
   Neuropharmacology, 56(1): 47-55. [Abstract] [Full-text]
7. Psychiatric disorders and repeat incarcerations: the revolving prison door.
   Am J Psychiatry, 166(1): 103-9. [Abstract] [Full-text]
8. Rating scales in bipolar disorder.
   Curr Opin Psychiatry, 22(1): 42-9. [Abstract] [Full-text]
9. Collaborative care for mood disorders.
   Curr Opin Psychiatry, 22(1): 37-41. [Abstract] [Full-text]
10. A developmental approach to the treatment of bipolar disorder: IPSRT with an adolescent.
    J Clin Nurs, 18(1): 141-9. [Abstract] [Full-text]
11. Coerced medication in psychiatric inpatient care: literature review.
    J Adv Nurs, 64(6): 538-48. [Abstract] [Full-text]
12. Electrophysiological correlates of sleep disturbance induced by acute and chronic administration of D-amphetamine.
    Brain Res, 1249: 162-72. [Abstract] [Full-text]
13. Fulminant hepatitis induced by lamotrigine.
    South Med J, 102(1): 82-4. [Abstract] [Full-text]
14. Valproate, a mood stabilizer, induces WFS1 expression and modulates its interaction with ER stress protein GRP94.
    PLoS ONE, 4(1): e4134. [Abstract] [Full-text]
15. Healthy babies for mothers with serious mental illness: A case management framework for mental health clinicians.
    Int J Ment Health Nurs, 17(6): 383-91. [Abstract] [Full-text]
16. Dopamine and impulse control disorders in Parkinson's disease.
    Ann Neurol, 64: S93-S100. [Abstract] [Full-text]
17. Psychopharmacological treatment before suicide attempt among patients admitted to a psychiatric intensive care unit.
    J Affect Disord, 113(1): 37-44. [Abstract] [Full-text]
18. Personality traits in children of parents with unipolar and bipolar mood disorders.
    J Affect Disord, 113(1): 133-41. [Abstract] [Full-text]
19. Reasons for substance use in dual diagnosis bipolar disorder and substance use disorders: a qualitative study.
    J Affect Disord, 113(1): 118-26. [Abstract] [Full-text]
20. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives.
    J Affect Disord, 113(1): 1-20. [Abstract] [Full-text]
21. Psychotherapeutic intervention and suicide risk reduction in bipolar disorder: a review of the evidence.
    J Affect Disord, 113(1): 21-9. [Abstract] [Full-text]
22. Potential Consumers' Attitudes Toward Psychiatric Genetic Research and Testing and Factors Influencing Their Intentions to Test.
    Genet Test. [Abstract] [Full-text]
23. Bridging the gap between schizophrenia and psychotic mood disorders: Relating neurocognitive deficits to psychopathology.
    Schizophr Res, 107(1): 69-75. [Abstract] [Full-text]
24. The relationship between migraine and mental disorders in a population-based sample.
    Gen Hosp Psychiatry, 31(1): 14-9. [Abstract] [Full-text]
25. Resting energy expenditure in manic episode.
    Bipolar Disord, 11(1): 102-6. [Abstract] [Full-text]
26. Functional polymorphism of the glucocorticoid receptor gene associates with mania and hypomania in bipolar disorder.
    Bipolar Disord, 11(1): 95-101. [Abstract] [Full-text]
27. Psychotherapy as monotherapy for the treatment of bipolar II depression: a proof of concept study.
    Bipolar Disord, 11(1): 89-94. [Abstract] [Full-text]
28. Polarity at illness onset in bipolar I disorder and clinical course of illness.
    Bipolar Disord, 11(1): 82-8. [Abstract] [Full-text]
29. Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression.
    Bipolar Disord, 11(1): 76-81. [Abstract] [Full-text]
30. Emotional hyper-reactivity in normothymic bipolar patients.
    Bipolar Disord, 11(1): 63-9. [Abstract] [Full-text]
31. Comparison of manic and depressive symptoms between children and adolescents with bipolar spectrum disorders.
    Bipolar Disord, 11(1): 52-62. [Abstract] [Full-text]
32. Conceptualizing impulsivity and risk taking in bipolar disorder: importance of history of alcohol abuse.
    Bipolar Disord, 11(1): 33-40. [Abstract] [Full-text]
33. Eyeblink conditioning anomalies in bipolar disorder suggest cerebellar dysfunction.
    Bipolar Disord, 11(1): 19-32. [Abstract] [Full-text]
34. White matter abnormalities in bipolar disorder and schizophrenia detected using diffusion tensor magnetic resonance imaging.
    Bipolar Disord, 11(1): 11-8. [Abstract] [Full-text]
35. TRPM2 variants and bipolar disorder risk: confirmation in a family-based association study.
    Bipolar Disord, 11(1): 1-10. [Abstract] [Full-text]
36. Mania in the Nordic countries: Patients and treatment in the acute phase of the EMBLEM study.
    Nord J Psychiatry. [Abstract] [Full-text]
37. P300 event-related potential in euthymic patients with bipolar disorder.
    Prog Neuropsychopharmacol Biol Psychiatry, 33(1): 16-9. [Abstract] [Full-text]
38. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Prog Neuropsychopharmacol Biol Psychiatry, 33(1): 94-9. [Abstract] [Full-text]
39. Classifying mood disorders by age-at-onset instead of polarity.
    Prog Neuropsychopharmacol Biol Psychiatry, 33(1): 86-93. [Abstract] [Full-text]
40. The Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (SILENT): one-year follow-up of a single case.
    J Neurol Sci, 277(1): 172-3. [Abstract] [Full-text]
41. Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts.
    Prog Neuropsychopharmacol Biol Psychiatry, 33(1): 109-12. [Abstract] [Full-text]
42. Pathways-based analyses of whole-genome association study data in bipolar disorder reveal genes mediating ion channel activity and synaptic neurotransmission.
    Hum Genet, 125(1): 63-79. [Abstract] [Full-text]
43. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study.
    Lancet, 373(9659): 234-9. [Abstract] [Full-text]
44. Dopamine D1 Receptor Gene Polymorphism is Associated with Prophylactic Lithium Response in Bipolar Disorder.
    Pharmacopsychiatry, 42(1): 20-2. [Abstract] [Full-text]
45. Characteristics of bipolar disorder in an Australian specialist outpatient clinic: comparison across large datasets.
    Aust N Z J Psychiatry, 43(2): 109-17. [Abstract] [Full-text]
46. Assessment of circadian function in fibroblasts of patients with bipolar disorder.
    Mol Psychiatry, 14(2): 143-55. [Abstract] [Full-text]
47. Identifying blood biomarkers for mood disorders using convergent functional genomics.
    Mol Psychiatry, 14(2): 156-74. [Abstract] [Full-text]
48. The 5-choice continuous performance test: evidence for a translational test of vigilance for mice.
    PLoS ONE, 4(1): e4227. [Abstract] [Full-text]
49. Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis.
    J Nerv Ment Dis, 197(1): 35-40. [Abstract] [Full-text]
50. Asenapine: a novel psychopharmacologic agent with a unique human receptor signature.
    J Psychopharmacol, 23(1): 65-73. [Abstract] [Full-text]
51. The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis?
    Depress Anxiety, 26(1): 73-82. [Abstract] [Full-text]
52. Olanzapine in long-term treatment for bipolar disorder.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
53. Mood disorders in children and adolescents.
    J Pediatr Nurs, 24(1): 13-25. [Abstract] [Full-text]
54. Role of an N-terminal splice segment in the activation of the cation channel TRPM2 by ADP-ribose and hydrogen peroxide.
    Neurochem Res, 34(2): 227-33. [Abstract] [Full-text]
55. Serum homocysteine levels and cognitive functioning in euthymic bipolar patients.
    J Affect Disord, 113(3): 285-90. [Abstract] [Full-text]
56. Long-term outcomes of youth who manifested the CBCL-Pediatric Bipolar Disorder phenotype during childhood and/or adolescence.
    J Affect Disord, 113(3): 227-35. [Abstract] [Full-text]
57. Lithium-associated hyperparathyroidism: report of four cases and review of the literature.
    Eur J Endocrinol, 160(2): 317-23. [Abstract] [Full-text]
58. Caught in the psychiatric net: meanings and experiences of ADHD, pediatric bipolar disorder and mental health treatment among a diverse group of families in the United States.
    Cult Med Psychiatry, 33(1): 61-85. [Abstract] [Full-text]
59. Circadian polymorphisms associated with affective disorders.
    J Circadian Rhythms, 7(1): 2. [Abstract] [Full-text]
60. No pathogenic rearrangement within the DISC 1 gene in psychosis.
    Am J Med Genet B Neuropsychiatr Genet, 150(1): 148-50. [Abstract] [Full-text]
61. Polymorphisms in the GRIA1 gene region in psychotic bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 150(1): 24-32. [Abstract] [Full-text]
62. Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice.
    Behav Brain Res, 198(1): 258-62. [Abstract] [Full-text]
63. The prevalence of mental disorders in adults in different level general medical facilities in Kenya: a cross-sectional study.
    Ann Gen Psychiatry, 8: 1. [Abstract] [Full-text]
64. Treatment patterns for schizoaffective disorder and schizophrenia among Medicaid patients.
    Psychiatr Serv, 60(2): 210-6. [Abstract] [Full-text]
65. Premature mortality from general medical illnesses among persons with bipolar disorder: a review.
    Psychiatr Serv, 60(2): 147-56. [Abstract] [Full-text]
66. Relation between cigarette smoking and cognitive function in euthymic individuals with bipolar disorder.
    Pharmacol Biochem Behav, 92(1): 12-6. [Abstract] [Full-text]
67. Prefrontal gyral folding and its cognitive correlates in bipolar disorder and schizophrenia.
    Acta Psychiatr Scand, 119(3): 192-8. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.